Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone vs Minoxidil in Female Pattern Hair Loss
NCT00175617Phase 2Completed
- Sponsor
- University of British Columbia
- Start
- Sep 2005
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of spironolactone in Female Pattern Hair Loss (FPHL) (2 arms), sponsored by University of British Columbia. Primary endpoint: Hair density at 9 months. Started Sep 2005; status: completed.
02
Drugs
spironolactone
03
Conditions
Female Pattern Hair Loss (FPHL)
Beyond the preview
Go deeper on NCT00175617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00175617.